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Although laparoscopic sleeve gastrectomy (LSG) is safe and efﬁcacious treatment for morbid obesity, this
procedure is associated with major staple line complications including leakage and bleeding. Staple-line
reinforcement (SLR) either through suturing or buttressing with biological or synthetic material has been
suggested as a method to prevent these complications. A Best Evidence Topic was constructed to address
the question of whether SLR reduced these and other complications. MEDLINE, EMBASE and CINAHL
searches up to October 2012 returned 97 unique results, of which nine (one meta-analysis, two rando-
mised controlled trials (RCTs), six prospective cohort studies) provided the best evidence to answer this
clinical question. We conclude that current evidence suggests that staple-line reinforcement reduces the
incidence of leakage and postoperative complications than non-reinforcement but does not signiﬁcantly
reduce bleeding complications. However, we cannot as yet recommend staple-line reinforcement as the
strength of the presented evidence is limited by the variable quality of the published studies. The full-
length publication of several abstracts of randomised, controlled trials presented at various recent
conferences is awaited. This may provide more data on the effect of staple-line reinforcement on other
outcomes largely neglected by currently available studies.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A best evidence article was constructed according to a struc-
tured protocol as described in a previous publication by the Inter-
national Journal of Surgery.12. Clinical scenario
You are seeing a patient in the bariatric outpatient department
who is being assessed for a laparoscopic sleeve gastrectomy (LSG)
for morbid obesity. Your standard practice has been not to rein-
force your staple-line but several previous LSGs in your depart-
ment have been complicated post-operatively by staple-line
bleeding and leaks. You decide to review the literature to deter-
mine whether or not staple-line reinforcement (SLR) during sleevertment of Surgery, Blackshaw
255.
.
ciates Ltd. Published by Elsevier Ltgastrectomy reduces the incidence of these and other adverse
outcomes.3. Three-part question
In patients undergoing laparoscopic sleeve gastrectomy, does
reinforcing the staple-line reduce the incidence of leakage,
bleeding, postoperative complications and other clinical outcomes?4. Search strategy
A search of the MEDLINE, EMBASE and CINAHL databases, up to
October 2012, using the NHS EVIDENCE interface (http://www.
library.nhs.uk/hdas) was undertaken using the following term:
Duplicate ﬁltered: [(sleeve AND gastrectomy).ti,ab AND (reinforc*
OR buttress* OR oversew*).ti,ab]
A separate search was performed on Google Scholar using the
same keywords. Further references were also searched from the
reference lists of articles returned by the search.d. All rights reserved.
Table 1
Best evidence papers.
Author [study groups] Study type and
level of evidence
Bleeding Leak rate Hospital stay Operative time Postoperative
complications
Choi et al. (2012) Korea2
[1345 patients undergoing
LSG: (A) staple-line
reinforcement (n ¼ 828)
and (B) no reinforcement
(n ¼ 517)]
Level I e Systematic
review including
two RCTs and six
cohort studies.
(A vs. B):
OR 0.559 (95% CI,
0.247e1.266)
(A vs. B):
OR 0.425 (95% CI,
0.226e0.799)
No comparison
data stated
No comparison
data stated
(A vs. B): OR 0.521
(95% CI, 0.349e0.777)
Consten et al. (2004) USA3
[Prospective consecutive
series of 20 patients
undergoing LSG: (A) 10
patients had staple-line
reinforcement with Gore
Seamguard and (B) 10
did not receive
reinforcement]
Level III Prospective
comparative cohort
study
(A vs. B):
120 ml  15 vs.
210 ml  20
(p < 0.05)
(A vs. B): 0 vs.0 (A vs. B):Inpatient
stay (days,
range, SE):
3.8 (2e8  1.2) vs.
4.6 (3e10  1.4)
(A vs. B): 204min
 11 vs. 210min
 14 (p < 0.05)
(A vs. B): 0 vs. 3
Dapri et al. (2009) Belgium4
[75 patients undergoing LSG:
(A) staple-line reinforcement
with Gore Seamguard
(n ¼ 25) and (B) oversewing
with 1.0 PDS (n ¼ 25), and
(C) no reinforcement
(n ¼ 25)]
Level II - Prospective,
randomised
controlled trial
(C vs. A vs. B):
48.9  67.1 mL (C)
vs. 32.5  46.5 mL
(A) vs. 61.9  69.4 ml
(B) (p < 0.05)
(C vs. A vs. B):
4% vs. 8% vs. 4%
(p < 0.05)
(C vs. A vs. B):
3.6  1.4 days vs.
3.9  1.5 days vs.
2.8  0.8 days
(p < 0.05)
(C vs. A vs. B):
47.4  10.7 min vs.
48.9  18.4 min vs.
59.9  19.6 min
(p < 0.05)
(C vs. A vs. B):
4% vs.0% vs. 4%
Stamou et al. (2011) Greece9
[187 patients undergoing
LSG : (A) 96 underwent
staple-line reinforcement
with Peri-strips Dry and
(B) 91 had no staple-line
reinforcement
Level III eProspective
comparative cohort
study
(A vs. B): 0 vs. 3
(p < 0.05)
(A vs. B): 2 vs. 4
(p > 0.05)
Median of 4 days
for both groups,
p > 0.05
No comparative
data stated
(A vs. B): 2 vs.
12 (p < 0.05)
Basso et al. (2010) Italy10
[300 consecutive patients
undergoing LSG :
(A) staple-line
reinforcement by
oversewing (n ¼ 200)
and (B) no staple-line
reinforcement (n ¼ 100)]
Level III Prospective
comparative cohort
study
(A vs. B): 5 vs. 8
(p < 0.05)
(A vs. B): 5 vs. 4
(p > 0.05)
No comparison
data stated
(A vs. B):
72  33.8 min vs.
119  48.6 min
(A vs. B): 12 (6%) vs.
15 (15%) (p < 0.05)
Ser et al. (2009) Taiwan8
[(A) 78 patients received
staple-line reinforcement
by suture oversewing and
(B) 40 who did not receive
staple-line reinforcement]
Level III Prospective
comparative cohort
study
(A vs. B):
47  31 ml vs.
84  99 ml
(p > 0.05)
(A vs. B): 0% vs.
10% (p < 0.05)
(A vs. B): 4.7 days
vs. 7.82 days
(p < 0.05)
(A vs. B):
119.8  31.4 min vs.
115.0  46.5 min
(p > 0.05).
(A vs. B): 5.13% vs.
12.5% (p > 0.05)
Daskalakis et al. (2009)Germany5
[(A)staple-line reinforcement
was done using either
Peri-strips Dry or oversewing
(n ¼ 144) and (B) 86 did
not have staple-line
reinforcement]
Level III Prospective
comparative cohort
study
(A vs. B): 2.8% vs.
7% (p > 0.05)
(A vs. B): 2.1% vs.
8.1% (p < 0.05)
No comparison
data stated
No comparative
data listed
(A vs. B): 6.2% vs.
16.3% (p < 0.05)
Sánchez-Santos et al. (2009)
Spain7 [540 patients
undergoing LSG between
2002 and 2008 across
17 centres in Spain :
(A) oversewing or
Seamguard (n ¼ 381)
and (B) no staple-line
reinforcement]
Level III e Prospective
multicentre cohort
study
(A vs. B): 0.4% vs.
1% (p > 0.05)
(A vs. B): 2.6% vs.
5.3% (p > 0.05)
No comparison
data stated
No comparison
data stated
(A vs. B): 3.7% vs.
8.8% (p < 0.05)
Musella et al. (2011) Italy6
[80 patients were
randomized to receive
either: (A) a polypropylene
3e0 running oversewing
suture of the staple-line
and (B) or no staple-line
reinforcement]
Level II Prospective
randomised clinical
study
(A vs. B): 4 (10%) vs.
2 (5%)
No comparison
data stated
No comparison
data stated
(A vs. B): 89  4 min
vs. 80  4 min
(p < 0.05)
(A vs. B): Fistulas:
1 (2.5%) vs. 2 (5%)
Stenosis: 4 (10%) vs. 0
Abbreviations: RCT ¼ randomised controlled trial, LSG ¼ laparoscopic sleeve gastrectomy, OR ¼ odds ratio, CI ¼ conﬁdence interval.
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REVIEW5. Search outcome
MEDLINE, EMBASE and CINAHL searches returned a total of 154
papers, of which 97 were unique results and 57 were duplicates.
After excluding 88 non-comparative studies, retrospective studies,
abstracts and review articles without meta-analyses, nine papers
which directly compared any type of staple line reinforcement with
a non-reinforcement control group were selected as representing
the best evidence to answer this clinical question. The search was
current as of October 2012.
6. Results
The key results from the nine papers are summarised in Table 1.
7. Discussion
Laparoscopic sleeve gastrectomy is a relatively new deﬁnitive
approach to the surgical management of morbid obesity.
Although this procedure has a low morbidity, potentially serious
staple line complications include leakage and bleeding. Rein-
forcement of the staple-line (SLR) has been proposed as a means
of reducing the risk of these complications and can be performed
by oversewing the staple-line with a suture or by buttressing the
staple line with either biological materials such as glycolide tri-
methylene carbonate copolymer (Gore Seamguard; W.L. Gore
and Associates, Inc, Flagstaff, AZ), porcine small bowel and bovine
pericardial strips (Peri-strips Dry; Synovis Surgical Innovations, St
Paul, MN) or synthetic materials such as polytetraﬂuoroethylene.
There is, however, much debate in the literature over the efﬁcacy
of SLR and, as such, this practice is performed variably by
surgeons.
With respect to the literature, the issue of staple line rein-
forcement was recently addressed in meta-analysis by Choi et al.2
This review included eight studies, seven3e9 of which are
included in our Table. Although the study by Choi et al. provides the
highest level of evidence to answer the clinical question to date, it is
beset by several limitations. For a start this systematic review
included some studies of poor methodological quality- in particular
note it included one cohort study10 which scored only ﬁve out of a
possible nine on the Newcastle-Ottawa scale of quality and
excluded the well-conducted prospective cohort study by Dapri
et al.4 In addition this study neglected to analyse signiﬁcant out-
comes such as hospital stay, cost and operative time. These de-
ﬁciencies in this meta-analysis necessitate the separate
consideration of other studies in this Best Bets. With respect to the
impact of SLR on clinical outcomes:
7.1. Effects of SLR on leakage, bleeding and postoperative
complications
The systematic review and meta-analysis by Choi et al. investi-
gated the effects of SLR on leakage, bleeding and postoperative
complications.2 They compared the incidence of these outcomes in
828 patients who underwent SLR and 517 controls that did not
undergo SLR. They found that the treatment group had signiﬁcantly
less leakage (OR 0.425 (95% CI, 0.226e0.799) and postoperative
complications (OR 0.521 (95% CI, 0.349e0.777) as compared to the
control group. A non-signiﬁcant reduction in bleeding rates was
also seen (OR 0.559 (95% CI, 0.247e1.266). However, subgroup
analyses showed that neither buttressing nor oversewing alone did
not have signiﬁcant effects on leak rates, however buttressing alone
probably decreases the risk of staple line haemorrhage and overall
complications.7.2. Effects of SLR on post-operative hospital stay
The length of stay in hospital following surgery was not
addressed in the systematic review by Choi et al. Although most
studies did not study this outcome,5,7,10 two studies showed a
signiﬁcant reduction in hospital stay between the groups.4,8 whilst
another two studies showed no signiﬁcant difference in the length
of stay.3,9 There is therefore insufﬁcient evidence for any valid
conclusions to be drawn regarding the effect of SLR on length of
postoperative hospital stay.
7.3. Effects of SLR on the operative time
In terms of operative time, three studies reported signiﬁcantly
longer operations in the treatment group.3,4,6 However, the signif-
icance of this ﬁnding is unclear as there is no evidence that this
necessarily increases complication rates. One study by Ser et al.
showed non-signiﬁcant differences between the study groups8
whereas two other studies did not provide a power calculation.5,9
Although most of the studies which compared operative times
showed that SLR leads to longer operations, the evidence for this is
weak and future studies are encouraged to include this outcome to
enable comparison.
7.4. Effects of SLR on cost of sleeve gastrectomy
With regard to costs, Dapri et al.4 noted the additional cost of the
Gore Seamguard per procedure ranged from V640 to V896. The
authors concluded that the potential for Gore Seamguard to
reduce bleeding seen in their study must be weighed against its
costs, particularly since it did not reduce leak rates. Consten et al.
also found an increase in cost of $650-$1300 per procedure when
using Gore Seamguard but argued that this was offset by the
reduction in hospital stay and morbidity.3 Although Stamou et al.
reported a median increase in the cost of each operation by
V1500eV2400, they failed to provide a cost analysis due to a lack of
reliable data from their accounting department.9 It is clear that
there are additional costs to SLR but formal cost-analyses need to be
undertaken to provide deﬁnitive answers on the economics of SLR.
7.5. Limitations
There are some important considerations before conclusions
can be drawn from the evidence currently available to answer the
clinical question. Some of the studies were signiﬁcantly under-
powered, had unclear participant selection methods, lack of a
deﬁned trial end-point, and inadequate standardisation of surgical
technique, all of which may have confounded the study’s results.
Also of note is that six of the nine included studies were non-
randomised prospective studies. However encouragingly more
than 11 abstracts of RCTs addressing this clinical question were
returned by the search. However, many of these are not yet pub-
lished as full length articles and were therefore not eligible for
inclusion to compile the best evidence currently available.
8. Clinical bottom line
Current evidence suggests that staple-line reinforcement
signiﬁcantly reduces the incidence of leakage and postoperative
complications but does not signiﬁcantly reduce bleeding compli-
cations. However, we cannot as yet recommend staple-line rein-
forcement as the strength of the presented evidence is limited by
the variable quality of the presented evidence. The full-length
publication of several abstracts of randomised, controlled trials
presented at various recent conferences is awaited. This may
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other outcomes largely neglected by currently available studies.
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